Robert A Lookstein MD, MHCDL

3.4K posts

Robert A Lookstein MD, MHCDL

@roblookstein

Executive Vice Chair, Department of Diagnostic, Molecular, and Interventional Radiology Mount Sinai Health System

New York, NY Katılım Nisan 2013

794 Takip Edilen6.1K Takipçiler

Sabitlenmiş Tweet

Robert A Lookstein MD, MHCDL@roblookstein·18 Eki

I ask my professional contacts and colleagues to follow this model. Please block all anonymous accounts. The tone of these accounts has become increasing aggressive and harmful. They do not deserve your attention. If you follow, you are endorsing this behavior on #medtwitter

Mount Sinai IR@MountSinaiIR

We have chosen to block all anonymous accounts as they do not represent our views. We recommend that our followers block them as well. Please do not ask us to respond to any content from anonymous accounts as they are not on our feed and not worthy of our (and your) attention.

English

114

Robert A Lookstein MD, MHCDL@roblookstein·3d

Live @SIRspecialists another pivotal trial result presented at #SIRT0R26 demonstrating the continued growth of deep venous interventions. venousnews.com/gore-viabahn-f…

English

550

Robert A Lookstein MD, MHCDL@roblookstein·17 May

Live #GEST2026 always great to get an impromptu strategic catch up between @SIRspecialists #Prez @saherssabri and yours truly as immediate #PastPrez

Robert A Lookstein MD, MHCDL tweet media

English

934

Robert A Lookstein MD, MHCDL retweetledi

Endovascular Today@EVToday·15 May

Examining the applications of embolization, a group from @IcahnMountSinai details how excellence can be achieved across diverse applications, underscoring the importance of technique refinement, cross-specialty collaboration, & procedural standardization. evtoday.com/articles/2026-…

English

683

Robert A Lookstein MD, MHCDL@roblookstein·15 May

Live @MountSinaiIR #GEST2026 #MeettheExperts with no other than @bonesz sharing tips for tackling complex #PAE cases @SIRspecialists

English

Robert A Lookstein MD, MHCDL@roblookstein·14 May

Live @MountSinaiIR our very own @RSP516 wins abstract of the year at #GEST2026 for his work as National PI for the OCCLUDE registry. 🙌👏

English

1.5K

Robert A Lookstein MD, MHCDL@roblookstein·13 May

#SIRTOR26 incredible memories...proud to serve @SIRspecialists and appreciate what we have accomplished as a team of dedicated volunteers and inspiring professional staff. Already looking forward to #SIRLA27

English

548

Robert A Lookstein MD, MHCDL@roblookstein·9 May

Live @MountSinaiIR innovation is what distinguishes our group, providing creative solutions for our patients. @DanShilo is leading our #MSK embolization program @MountSinaiNYC mountsinai.org/about/patient-…

English

1.4K

Robert A Lookstein MD, MHCDL@roblookstein·7 May

Live @MountSinaiIR Publication Alert!! Incredible effort to set the standard for #LRT for #HCC Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma | Radiology pubs.rsna.org/doi/10.1148/ra…

English

1.4K

Robert A Lookstein MD, MHCDL@roblookstein·2 May

Live @MountSinaiIR we are proud to share we performed 56 outpt embolizations for UFE,PAE,GAE, and HAE at our Embolization Center of Excellence @MountSinaiNYC WestCampus in April. This is a testament to our MDs, nurses, technologists, office staff, and our patients. TYSM!!

English

2.6K

Robert A Lookstein MD, MHCDL@roblookstein·24 Nis

Live @SIRspecialists Is It Time to Rethink PE Treatment? Functional Outcomes From STORM‑PE physiciansweekly.com/post/is-it-tim…

English

1.2K

Robert A Lookstein MD, MHCDL@roblookstein·22 Nis

Live @CXSymposium at the end of the Pulm Embolism morning session and review of all the new trial data, the audience clearly believes reperfusion therapy will continue to grow over the next several months/years. @SIRspecialists @SCAI @VascularSVS @SVM_tweets @VIVAPhysicians

English

496

Robert A Lookstein MD, MHCDL@roblookstein·22 Nis

Live @CXSymposium more discussion on the New Pulm Embolism Guidelines from @RKolluriMD

English

690

Robert A Lookstein MD, MHCDL@roblookstein·22 Nis

Live #CX2026 The Pulmonary Embolism Consensus Session is underway with @adityasharmamd

English

564

Robert A Lookstein MD, MHCDL retweetledi

TCTMD@TCTMD·20 Nis

STORM-PE: Mechanical Thrombectomy Boosts Walking and Daily Living Gains dlvr.it/TS7Srl

English

509

Robert A Lookstein MD, MHCDL retweetledi

Interventional News@IN_publishing·12 Nis

STORM-PE 90-day results demonstrates greater improvement in functional outcomes using #CAVT compared to patients who received anticoagulation alone, reports @roblookstein, adding that CAVT patients walked "significantly farther" at follow-up #SIR26TOR @SIRspecialists

English

433

Robert A Lookstein MD, MHCDL retweetledi

Interventional News@IN_publishing·12 Nis

#SIR26TOR: 12-month IN.PACT AV Access post-approval study results show a 70% rate of target-lesion primary patency and 80.6% freedom from all-cause mortality in 159 patients, with no new safety concerns reported when compared to IN.PACT AV randomised controlled trial

English

508

Robert A Lookstein MD, MHCDL retweetledi

Interventional News@IN_publishing·13 Nis

“We have provided new hope for post-thrombotic syndrome [PTS] patients” said Suresh Vedantham (St Louis), presenting the C-TRACT trial results which showed in patients with moderate or severe PTS, endovascular therapy reduced symptom severity and improved QOL #SIR26TOR

English

991

Robert A Lookstein MD, MHCDL retweetledi

Interventional News@IN_publishing·13 Nis

The 90-day results of the STORM-PE RCT have demonstrated that patients with acute intermediate-high risk #PE who were treated with #CAVT plus anticoagulation achieved greater functional improvement @roblookstein @SIRspecialists #SIR26TOR interventionalnews.com/new-storm-pe-d…

English

1.3K

Robert A Lookstein MD, MHCDL retweetledi

Mount Sinai Diag, Molecular, and Interv Radiology@MountSinaiDMIR·15 Nis

STORM-PE 90-day results show CAVT + anticoagulation significantly improves functional outcomes in intermediate-high risk PE-patients walked farther and more reached NYHA Class I vs anticoagulation alone, with comparable safety. vascularnews.com/new-storm-pe-d…

English

663

Robert A Lookstein MD, MHCDL@roblookstein·15 Nis

@AustinBourgeois what device is this? many of the newer devices are incredibly flexible and trackable: @InnovaVascular @ImpCare_Vasc @PenVascular

English

423

Austin Bourgeois@AustinBourgeois·12 Nis

One of the more difficult PE scenarios: Organized clot in the left lower lobe in an unstable patient #iRad #PERT FWIW I don't recommend working over a glidewire!

English

5.8K

Keşfet

@SIRspecialists @saherssabri @IcahnMountSinai @MountSinaiIR @bonesz @RSP516 @DanShilo @MountSinaiNYC